Benzinga

Benzinga Research

Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise

Benzinga

Premium Services
Financial News
Financial News
Large Cap Stocks
Small-Cap Stocks
Insider Trades
Earnings
Technology
AI News
Personal Finance
ETF News
Crypto News
Dividend News
Latest Rumors
Latest Offerings News
Investment Ideas
Investment Ideas
Stock of the Day
Stock Whisper Index
Analyst Ratings
Analyst Color
Financial Advisors
Government Trades
Trading Ideas
Stock Screener
Markets
Markets
Premarket Movers
After Hours
Options
ETFs
Commodities
Prediction Markets
Private Markets
Bonds
Futures
Forex
Top Stocks
Top Stocks
Apple (AAPL)
Tesla (TSLA)
Amazon (AMZN)
Nvidia (NVDA)
Alphabet (GOOGL)
Meta Platforms (META)
Microsoft (MSFT)
StreetTracks Gold Shares (GLD)
IBIT Bitcoin Trust (IBIT)
Top Value Stocks
Top Momentum Stocks
Top Growth Stocks
Top Quality Stocks
Learn
Learn
Investing Guides
Personal Finance
Mortgages
Best Credit Cards
Best Dividend Stocks
Best Swing Trade Stocks

Free Benzinga Pro Trial

Calendars

Analyst Ratings Calendar

Conference Call Calendar

Dividend Calendar

Earnings Calendar

Economic Calendar

Events Calendar

Guidance Calendar

Unusual Options Activity Calendar

Stock Split Calendar

Trade Ideas

Trade Idea Feed

Analyst Ratings

Unusual Options Activity

Free Newsletter

Government Trades

Perfect Stock Portfolio

Easy Income Portfolio

Short Interest

Largest Increase

Largest Decrease

Calculators

Options Profit Calculator

Margin Calculator

Forex Profit Calculator

100x Options Profit Calculator

Covered Call Calculator

Cash-Secured Put Calculator

Long Call Calculator

Long Put Calculator

Screeners

Top Momentum Stocks

Top Quality Stocks

Top Value Stocks

Top Growth Stocks

Compare Best Stocks

Best Momentum Stocks

Best Quality Stocks

Best Value Stocks

Best Growth Stocks

Xeris Biopharma Holdings Inc Stock News

XERSNASDAQ

Trade with Public

Trade with Public

$7.87

0.131.61%

Last update: Jun 30, 2:16 PM

OverviewNewsEarnings Events Options Guidance Analyst Ratings Insider Trades Short Interest Stock Report

Latest Xeris Biopharma Holdings Stock News | NASDAQ:XERS | Benzinga

Get the latest news on Xeris Biopharma Holdings stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on Xeris Biopharma Holdings performance

Categories: All

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

Thursday, June 11, 2026

PRO
Xeris Pharmaceuticals Issued Notice Of Allowa...
Benzinga Newsdesk
PRO
Xeris Biopharma Enters Separate Exchange Agre...
Benzinga Newsdesk

Thursday, May 07, 2026

PRO
Xeris Biopharma Holdings Raises FY2026 Sales ...
Benzinga Newsdesk
PRO
Xeris Biopharma Holdings Q1 EPS $0.01 Beats $...
Benzinga Newsdesk

Monday, March 02, 2026

PRO
HC Wainwright & Co. Reiterates Buy on Xeris B...
Benzinga Newsdesk
Xeris Biopharma Holdings Q4 Earnings Assessment
Benzinga Insights
PRO
Xeris Biopharma Holdings Sees FY2026 Sales $3...
Benzinga Newsdesk
PRO
Xeris Biopharma Holdings Q4 EPS $0.06 Beats $...
Benzinga Newsdesk
Earnings Scheduled For March 2, 2026
Benzinga Insights

Friday, February 27, 2026

Why Are Shares Of Xeris Biopharma Falling Friday?
Alex Perry
A Peek at Xeris Biopharma Holdings's Future Earnings
Benzinga Insights

Thursday, February 26, 2026

PRO
Xeris Biopharma's Subsidiaries, Xeris Pharmac...
Benzinga Newsdesk

Friday, January 09, 2026

PRO
HC Wainwright & Co. Reiterates Buy on Xeris B...
Benzinga Newsdesk

Thursday, January 08, 2026

PRO
Xeris Biopharma Holdings shares are trading h...
Benzinga Newsdesk
PRO
Xeris Expects Record Q4 And FY 2025 Revenue O...
Benzinga Newsdesk

Friday, January 02, 2026

Outlook Therapeutics, Intelligent Bio Solutions And Other Big Stocks Moving Lower In Friday's Pre-Market Session
Avi Kapoor

Tuesday, December 09, 2025

PRO
Barclays Initiates Coverage On Xeris Biopharm...
Benzinga Newsdesk

Monday, December 01, 2025

PRO
Xeris Announces Notice Of Allowance From USPT...
Benzinga Newsdesk

Thursday, November 06, 2025

PRO
Xeris Biopharma Holdings shares are trading l...
Benzinga Newsdesk
PRO
Xeris Biopharma Holdings Raises FY2025 Sales ...
Benzinga Newsdesk
PRO
Xeris Biopharma Holdings Q3 Sales $74.380M Be...
Benzinga Newsdesk
Earnings Scheduled For November 6, 2025
Benzinga Insights

Wednesday, August 27, 2025

PRO
American Regent And Xeris Pharmaceuticals Lau...
Benzinga Newsdesk

Monday, August 25, 2025

PRO
Xeris Announces US Patent Listing In Orange B...
Benzinga Newsdesk

Tuesday, August 12, 2025

PRO
HC Wainwright & Co. Assumes Xeris Biopharma H...
Benzinga Newsdesk

Thursday, August 07, 2025

PRO
Xeris Biopharma Holdings shares are trading h...
Benzinga Newsdesk
PRO
Xeris Biopharma Holdings Raises FY2025 Sales ...
Benzinga Newsdesk
PRO
Xeris Biopharma Holdings Q2 EPS $(0.01) Beats...
Benzinga Newsdesk
Earnings Scheduled For August 7, 2025
Benzinga Insights

Tuesday, June 03, 2025

PRO
Xeris Biopharma Holdings shares are trading l...
Benzinga Newsdesk

Friday, May 09, 2025

PRO
Oppenheimer Maintains Outperform on Xeris Bio...
Benzinga Newsdesk

Thursday, May 08, 2025

PRO
Xeris Biopharma Holdings Raises FY2025 Sales ...
Benzinga Newsdesk
PRO
Xeris Biopharma Holdings Q1 EPS $(0.06) Misse...
Benzinga Newsdesk
Earnings Scheduled For May 8, 2025
Benzinga Insights

Wednesday, May 07, 2025

Earnings Outlook For Xeris Biopharma Holdings
Benzinga Insights

Monday, March 17, 2025

PRO
Xeris Announces FDA Approval Of Supplemental ...
Benzinga Newsdesk

Friday, March 07, 2025

PRO
Piper Sandler Reiterates Neutral on Xeris Bio...
Benzinga Newsdesk
PRO
HC Wainwright & Co. Reiterates Buy on Xeris B...
Benzinga Newsdesk

Thursday, March 06, 2025

PRO
Xeris Biopharma shares are trading higher aft...
Benzinga Newsdesk
PRO
Xeris Biopharma Expects 2025 Revenue Of $255M...
Benzinga Newsdesk
PRO
Xeris Biopharma Holdings Q4 2024 GAAP EPS $(0...
Benzinga Newsdesk
Earnings Scheduled For March 6, 2025
Benzinga Insights

Monday, February 03, 2025

PRO
Jefferies Reiterates Buy on Xeris Biopharma H...
Benzinga Newsdesk

Tuesday, January 21, 2025

PRO
American Diabetes Association And Xeris BioPh...
Benzinga Newsdesk

Friday, January 10, 2025

PRO
Xeris Biopharma Expects To Generate 2024 Reve...
Benzinga Newsdesk

Monday, November 11, 2024

PRO
HC Wainwright & Co. Maintains Buy on Xeris Bi...
Benzinga Newsdesk
Sapiens International Posts Downbeat Results, Joins Sky Harbour And Other Big Stocks Moving Lower In Monday's Pre-Market Session
Avi Kapoor
PRO
Piper Sandler Downgrades Xeris Biopharma Hold...
Benzinga Newsdesk

Friday, November 08, 2024

PRO
Xeris Biopharma Raises Its 2024 Revenue Guida...
Benzinga Newsdesk
PRO
Xeris Biopharma Holdings Q3 2024 Adj EPS $(0....
Benzinga Newsdesk

Connect With Us

About Benzinga

About Us
Careers
Advertise
Contact Us

Market Resources

Advanced Stock Screener Tools
Options Trading Chain Analysis
Comprehensive Earnings Calendar
Dividend Investor Calendar and Alerts
Economic Calendar and Market Events
IPO Calendar and New Listings
Market Outlook and Analysis
Wall Street Analyst Ratings and Targets

Trading Tools & Education

Benzinga Pro Trading Platform
Options Trading Strategies and News
Stock Market Trading Ideas and Analysis
Technical Analysis Charts and Indicators
Fundamental Analysis and Valuation
Day Trading Guides and Strategies
Live Investor Events
Pre-market Stock Analysis and News
Cryptocurrency Market Analysis and News

Ring the Bell

A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.

Terms & Conditions
Do Not Sell My Personal Data/Privacy Policy
Disclaimer
Service Status
Sitemap

© 2026 Benzinga | All Rights Reserved